DSC
MRNA icon

Daytona Street Capital’s Moderna MRNA Stock Holding History

Daytona Street Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02K Hold
15
– – ﹤0.01% 270
2026
Q1 		$767 Hold
15
– – ﹤0.01% 293
2025
Q4 		$442 Buy
+15
New +$408 ﹤0.01% 301

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Daytona Street Capital's MRNA Position: Q2 2026 in Review

Daytona Street Capital held its Moderna (MRNA) position steady in Q2 2026 at 15 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #270.

Daytona Street Capital first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 371 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Daytona Street Capital held 15 shares of Moderna worth $1.02K as of Q2 2026.
  • Daytona Street Capital left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Daytona Street Capital's portfolio in Q2 2026, its #270 holding.
  • Daytona Street Capital first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • 371 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Daytona Street Capital's 13F filing for Q2 2026, filed 3 Aug 2026.